The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence. Ignatiadis, M.; Azim, H. A.; Desmedt, C.; Veys, I.; Larsimont, D.; Salgado, R.; Lyng, M. B.; Viale, G.; Leyland-Jones, B.; Giobbie-Hurder, A.; Kammler, R.; Dell'Orto, P.; Rothe, F.; Laios, I.; Ditzel, H. J.; Regan, M. M.; Piccart, M.; Michiels, S.; Sotiriou, C.. JAMA Oncol. 2016; 217-24: p.217-24. doi:10.1001/jamaoncol.2015.4377 10.1001/jamaoncol.2015.4377.

Article